CONTEXT AND OBJECTIVE: Diet is an important modifiable factor involved in obesity-induced inflammation. We reviewed clinical trials that assessed the effect of consumption of different fatty acids on the expression of inflammation-related genes, such as cytokines, adipokines, chemokines and transcription factors. DESIGN AND SETTING: Narrative review study conducted at a research center.
INTRODUCTION

Inflammation is a physiological response triggered by infection
and injury that has the purposes of eliminating irritating agents and accelerating tissue regeneration. 1, 2 In this process, several inflammatory mediators are released, including cell adhesion molecules, cytokines, chemokines and other inflammatory agents (e.g. nitrogen and reactive oxygen species). 3 In order to maintain the homeostatic balance, a controlled inflammatory response is required. On the other hand, excessive or inappropriate inflammation leads to a pathological inflammatory status. 1 Increasingly, there is evidence to suggest that a deregulated inflammatory response plays a pivotal role in the onset and progression of atherosclerosis. 4 Moreover, excessive adiposity and adiposity-related metabolic diseases (metabolic syndrome, diabetes and atherosclerosis) are attributed to a chronic state of low-grade inflammation. Therefore, diet-induced weight loss is an important factor for reducing pro-inflammatory markers. [5] [6] [7] In fact, besides lipid storage, fat cells are capable of producing and secreting chemoattractants such as monocyte chemotactic protein-1 (MCP-1)
and pro-inflammatory mediators such as interleukins (IL), for instance IL-1β, IL-6 and tumor necrosis factor (TNF)-α, during adipose tissue expansion, thereby resulting in inflammatory and metabolic deregulation. 8 Many environmental factors can contribute towards obesity and thus interfere with inflammatory expression, including diet. 9 Nutritional interventions can modulate inflammation, as demonstrated in studies based on a hypocaloric diet or on high consumption of fruits and vegetables. Both interventions have been shown to reduce the expression and synthesis of pro-inflammatory cytokines (IL-6 and TNF-α) and decrease other inflammatory markers such as C-reactive protein (CRP). [10] [11] [12] In addition, previous studies have confirmed that high-fat meals reduce leptin concentrations and increase the activation of inflammatory markers such as IL-6 during the postprandial phase. 13, 14 In fact, fatty acids can directly or indirectly modify immune and inflammatory responses. Current evidence suggests that a family of receptors involved in innate immunity, known as Toll-like receptors (TLRs), is connected with the inflammatory response relating to saturated fatty acid (SFA) intake. In this regard, it has been proposed that SFAs are nonmicrobial TLR agonists that promote inflammatory activation. 15 Studies have
shown that the SFA lauric acid stimulates pro-inflammatory expression by TLR2 and TLR4, thereby mediating nuclear factor kappa B (NF-κB) and cyclooxygenase-2 activation and expression.
In contrast, consumption of fish oil rich in n3 polyunsaturated fatty acid (PUFA) inhibits the TLR4-induced signaling pathways and target gene expression. 16, 17 Moreover, SFA intake is known to cause lipemia that is more pronounced than the lipemia due to monounsaturated fatty acids (MUFA) and PUFA, which can lead to a higher pro-inflammatory state associated with SFA consumption. 18 Additionally, SFA palmitate and stearate acids can trigger IL-1β secretion through mechanisms involving NLRP3
(NOD-like receptor family, pyrin domain containing 3) inflammasome activation. 19 Recently, it was proposed that GPR120 (G protein-coupled receptor 120) mediates the anti-inflammatory effects of n3
PUFA. 20, 21 Dietary n3 PUFA has been correlated with inhibition of TLR-induced signaling pathways and target gene expression, probably through disruption of translocation of TLR4 into a lipid raft. 16, 17 In combination, these mechanisms can potentially inhibit the signaling pathways that lead to NF-κB activation, thus resulting in downregulation of pro-inflammatory responses through n3 PUFA intake.
OBJECTIVE
Given the above, we aimed to summarize and discuss recent evidence about the effect of consumption of different fatty acids in humans, on inflammation-related gene expression, as evaluated through clinical studies.
METHODS
This was a narrative review of the English-language literature on the effects of fat intake on inflammatory gene expression in humans. It evaluated studies indexed in the Cochrane Library, LILACS and PubMed databases between the time of database inception and March 2016 ( Table 1) . We included original studies that reported on clinical trials on men or women (not pregnant, not in lactation and not in the postmenopausal period) who were not athletes, not undergoing hormonal treatment, not dependent on alcohol or drugs and not suffering from chronic illnesses (such as hepatic, renal, thyroid or cardiac dysfunction) or acute inflammatory processes.
Since the objective was to evaluate the effect of fatty acid consumption among humans, only clinical trials were included,
given that these are considered to be the mainstay design for causal inferences.
All the papers were checked according to their titles and abstracts (screening). Full papers were obtained from journals available on the CAPES Foundation (Ministry of Education, Brazil)
website. Unavailable articles were requested from their authors.
Articles presenting potentially relevant studies were read and analyzed to assess the inclusion criteria.
We excluded articles that consisted of in vitro or animal studies, articles in which the participants' characteristics did not match those mentioned above, poster session abstracts, review articles and other types of publications (non-standard
Database
Search Filters Results
Cochrane Library ("gene expression" OR "RNA" OR "mRNA" OR "gene") AND (("saturated fatty acid" OR "saturated fatty acids" OR "SFA" OR "SFAs") OR ("monounsaturated fatty acid" OR "monounsaturated fatty acids" OR "MUFA" OR "MUFAs") OR ("polyunsaturated fatty acid" OR "polyunsaturated fatty acids" OR "PUFA" OR "PUFAs")) AND ("inflammation" OR "inflammatory" OR "proinflammatory") Title, abstract, keywords in trials 48 articles 2 animal/in vitro studies 3 poster session abstracts 43 clinical trials LILACS ("gene expression" OR "RNA" OR "mRNA" OR "gene") AND (("saturated fatty acid" OR "saturated fatty acids" OR "SFA" OR "SFAs") OR ("monounsaturated fatty acid" OR "monounsaturated fatty acids" OR "MUFA" OR "MUFAs") OR ("polyunsaturated fatty acid" OR "polyunsaturated fatty acids" OR "PUFA" OR "PUFAs")) AND ("inflammation" OR "inflammatory" OR "proinflammatory")
No filter 2 articles 2 reviews PubMed ("gene expression" OR "RNA" OR "mRNA" OR "gene") AND (("saturated fatty acid" OR "saturated fatty acids" OR "SFA" OR "SFAs") OR ("monounsaturated fatty acid" OR "monounsaturated fatty acids" OR "MUFA" OR "MUFAs") OR ("polyunsaturated fatty acid" OR "polyunsaturated fatty acids" OR "PUFA" OR "PUFAs")) AND ("inflammation" OR "inflammatory" OR "proinflammatory") ferentiation between the total polyunsaturated, monounsaturated and saturated fatty acid content used to compare the interventions). The flowchart for the study selection process is described in Figure 1 . Other papers were used for contextualization and discussion.
RESULTS
We identified 14 studies that investigated the effect of fatty acid intake on inflammatory gene expression ( Table 2) . Six of these studies had a postprandial design in which an acute inflammatory response to a high-fat meal consumed on a single day was evaluated 22, 23 or consisted of a postprandial fat challenge, reflecting fat composition similar to that of a dietary intervention conducted for at least four weeks afterwards. [24] [25] [26] [27] Postprandial is a term that was introduced in 1997 and refers to "the time frame after a meal or food intake". 28 Seven studies assessed the inflammatory response after long-term consumption (minimum of 8 weeks). [29] [30] [31] [32] [33] [34] [35] Lastly, one study determined both the postprandial and the long-term response to the same dietary intervention. 36 In order to assist comparisons between the studies, dietary interventions were compared according to fat content source (SFA, MUFA or PUFA) and its respective proportion of total energy intake (E%).
Inflammatory genes were analyzed in duodenal tissue, peripheral blood mononuclear cells (PBMCs), subcutaneous or visceral adipose tissue, skeletal muscle and whole blood, Figure 1 . Literature search process.
We excluded references if they consisted of an in vitro or animal study; because of some characteristics of the participants (pregnancy, lactation, menopause, athlete, hormonal treatment, alcohol or drug dependence, chronic illness such as hepatic, renal, thyroid or cardiac dysfunction, or acute inflammation process); or if they were poster session abstracts, review articles or other types (non-standard dietary interventions; studies on drug therapy; studies without analysis on inflammation; dietary trial intervention with fatty acid intake along with vitamin or mineral supplementation; studies on heated oils; or studies without a clear difference between the total polyunsaturated, monounsaturated and saturated fatty acid content that was used to compare the interventions). Table 2 . Continues n = number of subjects; M/F = male/female; N/A = not available; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; n3 PUFA = n3 polyunsaturated fatty acids; LFHCC n3 = high complex carbohydrate supplemented with n3 PUFA; LFHCC = high complex carbohydrate supplemented with placebo; ALA = α-linolenic acid; LA = linoleic acid; E% = % of energy intake; PBMC = peripheral blood mononuclear cells; SAT = subcutaneous adipose tissue; VAT = visceral adipose tissue; ADIPOR = adiponectin receptor; ADIPQ = adiponectin gene; CD14, CD163, CD16A, CD206, CD284, CD40, CD68 = macrophage markers; HIF1α = hypoxia-induced factor 1α; ICAM-1 = intercellular adhesion molecule-1; IL = interleukin; IκB = inhibitor of NF-κB; LEP = leptin; LEPR = leptin receptor; MCP-1 = monocyte chemoattractant protein-1; MIF = macrophage migration inhibitory factor; MIP-1 = macrophage inflammatory protein 1; MMP-9 = matrix metalloproteinase 9; MRC1 = mannose receptor C type 1; NFkB1 = nuclear factor kappa-B subunit 1; p65 = nuclear p65 protein; RBP4 = retinol binding protein 4; SAA1 = serum amyloid A1; TGF-β1 = transforming growth factor β1; TLR4 = Toll-like receptor 4; TNF-α = tumor necrosis factor alpha; TNFRSF1A = tumor necrosis factor receptor superfamily member 1A. *Mediterranean (MED) diet components high in MUFA from extra-virgin olive oil and containing additional MED components (i.e. fatty fish, unrefined grain products, nuts, legumes and red wine). §
The SFA meal was high in coconut oil with 49 E% from medium-chain SFA (predominantly lauric acid) and 30 E% from long-chain SFA (predominantly myristic acid).
mostly using the polymerase chain reaction (PCR), or using a microarray analysis methodology. The main inflammatory genes screened were those that promote expression of adipokines, chemokines, cytokines and transcription factors. Hence, before discussing the role of fatty acid intake in inflammatory gene expression, we firstly contextualize the main markers that have been found in various studies.
Adipokines
Adipose tissue is an active organ involved not only in energy storage control, but also in regulation of complex metabolic and endocrine functions. In this context, adipose tissue releases cytokines and other bioactive mediators. Adiponectin and leptin are known as true adipokines, and are the major adipocyte proteins produced mainly by adipose tissue. 37, 38 In particular, adiponectin is an anti-inflammatory cytokine that might be able to induce production of other anti-inflammatory cytokines such as IL-10 and IL-1 receptor antagonist (IL-1RA). At the same time, it may suppress pro-inflammatory cytokine production of interferon (IFN)-γ 37 and may also have a negative correlation with CRP, the systemic inflammatory marker. 39 Moreover, adiponectin can exhibit atheroprotective effects, through attenuating chronic inflammation in vascular walls. 40 On the other hand, leptin correlates directly with body fat mass and adipocyte size, and has a role as a pro-inflammatory cytokine. Leptin stimulates production of several inflammatory mediators such as IL-1, IL-6, IL-12 and TNF. 37 In addition, leptin has been correlated with several obesity-associated diseases such as cardiovascular diseases and diabetes. 
NF-κB signaling is controlled through NF-κB inhibitors (IκB).
This is a family of proteins that can bind NF-κB dimers in the cytoplasm and nucleus, thereby inhibiting the NF-κB transcriptional response. 63 Certain stimuli result in phosphorylation, and subsequent proteasome-mediated degradation of IkB proteins allows the unbound NF-κB dimers to translocate to the nucleus, thereby regulating the expression of target genes. as well as higher IL-6 plasma concentrations, 27 thus suggesting that a greater inflammatory response would be expected in these subjects. In fact, non-dietary factors, such as obesity and type 2 diabetes, can increase the extent of fatty acid postprandial inflammatory response. 67 However, the source of fats was not mentioned in the study and it is known that dietary fat sources differ in more aspects than only their fatty acid profiles.
In this regard, olive oil is well known for its potential healthpromoting properties, which are due to the presence of high levels of MUFA and other valuable minor components such as phenolics, phytosterols, tocopherols, carotenoids, chlorophyll and squalene. 68 These natural compounds with antioxidant and other potentially important types of bioactivity have a beneficial impact on inflammatory markers. 67 Thus, they represent an important confounding factor in assessing the effect of dietary fat intake on the inflammatory response.
Controversially, high-SFA acute intake (46. Palm oil use is subject to debate with regard to potential unhealthy effects, because of its high palmitic acid content. An increased inflammatory response (IL-6) relating to a palmitic oil-enriched diet in mice and a similar effect from palmitic acid in vitro was shown in one study. However, apart from SFAs, which are mostly from palmitic acid, this plant oil contains oleic and linoleic acids, which are MUFA and PUFA, respectively. 69 Unlike in other studies, a much higher amount of MUFA was used, in comparison with the SFA intervention. In addition, n3 PUFA intake was greater than in other studies.
However, in a long-term dietary trial on the inflammatory response in PBMCs, gene expression remained unchanged after eight weeks of intervention with SFAs (19 E%), among abdominally obese patients. 30 This result may be related to the lower amount of fat provided, in comparison with other interventions. Moreover, presence of the obese phenotype was correlated with a previous abnormal inflammatory profile. 30 On the other hand, in subcutaneous adipose tissue among abdominally overweight subjects, investigation of a long-term SFA diet (19 E%) regarding the inflammatory response showed that upregulation of genes mainly relating to immune and inflammatory pathways occurred. At the same time, downregulation of anti-inflammatory genes and reduction of plasma adiponectin concentration were also observed. 33 Among healthy subjects, an acute dietary intervention that was high in medium-chain SFAs (79 E%),
i.e. rich in coconut oil, induced a postprandial pro-inflammatory response relating to several inflammatory genes in subcutaneous adipose tissue (CD16a, IL-1β, IL-6, IL-6R and TNF-α) and muscle tissue (MCP-1, IL-6R, CD16a, LEP, TLR4 and TNF-α).
Additionally, plasma IL-6 concentration increased in response to medium-chain SFA consumption. 23 In this regard, SFA appears to be able to modulate gene expression in important sources of inflammatory markers, such as PBMCs and adipose tissue.
Regarding the effect of MUFA consumption on inflammatory gene expression in subcutaneous adipose tissue, acute MUFA intake (72 E%) containing macadamia nut oil induced a postprandial antiinflammatory response (ADIPOQ) in healthy subjects. However, it also increased the pro-inflammatory gene expression (TNFRSF1A), but in a less pronounced manner than did SFA (79 E%) derived from coconut oil intake. 23 Moreover, a long-term MUFA (20 E%) dietary intervention, mainly in the form of refined olive oil, among abdominally obese subjects for eight weeks, also resulted in downregulation or unchanged expression of pro-inflammatory genes in subcutaneous adipose tissue, compared with a SFA diet (19%). 33 These results indicate that MUFA can also exert a pro-inflammatory response, but only weakly, compared with SFA consumption. In fact, unlike SFAs, unsaturated fatty acids such as oleate acid were unable to activate the NLRP3 inflammasome and thereby stimulate IL-1β production. 19 However, other mechanisms may be involved in the inflammatory response mediated by MUFA intake, which can elicit a pro or anti-inflammatory response.
Among subjects at higher risk of type 2 diabetes, an acute postprandial intervention of MUFA breakfast (72 E%) containing macadamia nut oil showed that several inflammatory genes were upregulated in subcutaneous adipose tissue (MCP-1, IL-1β, IL-6, IL-6R, TNF-α and TNFRSF1A). However, healthy subjects showed upregulation of proinflammatory genes (TNFRSF1A) but also of anti-inflammatory ones such as ADIPOQ. 23 Metabolic syndrome patients also showed an increased postprandial response of inflammatory genes (p65, MCP-1, IL-6 and IL-1β) and anti-inflammatory genes (IκBα) in subcutaneous adipose tissue, regardless of the quality of dietary fat (SFA from animal fat, 38 E%; MUFA mainly from olive oil, 43 E%; or n3 PUFA, 1.24 g). 25 These results suggest that pro-inflammatory expression of adipose tissue would be expected among obesity-related diseases. This has been correlated with overproduction of pro-inflammatory adipocytokines.
As mentioned earlier, obesity and type 2 diabetes can elicit a pronounced postprandial inflammatory response. 67 Furthermore, the major characteristic of the Mediterranean diet is a high amount of MUFA (around 20 E%), mainly from olive oil intake. 70 The Mediterranean dietary pattern has been correlated with reduced cardiovascular morbidity and mortality. 70, 71 This diet has been encouraged because of its relationship with an improved cardiovascular profile, including its favorable effect on blood pressure, insulin sensitivity, lipid profiles, lipoprotein particles, oxidative stress, carotid atherosclerosis and inflammation. 11, 72 In a study investigating the effect of consumption of a diet rich in extra-virgin olive oil (MUFA; 21 E%) containing additional
Mediterranean components (i.e. fatty fish, unrefined grain products, nuts, legumes and red wine), no effect was found on PBMC inflammatory genes. 35 These authors suggested that the lack of effect was attributable to the low expression of those markers and therefore that they were unlikely to be further modified. However, their study focused on a small number of markers (IL-6, IL-18 and TNF-α) and did not assess any anti-inflammatory markers.
FINAL CONSIDERATIONS
In summary, the studies reviewed here indicate that MUFA intake and n3 PUFA intake exhibit anti-inflammatory profiles or at least a less pronounced pro-inflammatory response, particularly in comparison with SFA consumption. However, some conflicting results have been described in comparing the inflammatory effects between them. The variability in doses of MUFA (20 E% to 72 E%) and n3 PUFA (0.4 g to 23.7 E%) that were used in interventions may have led to these conflicting results. In addition, the variability in intestinal microbiota among individuals seems to be involved in this postprandial inflammatory response.
In this regard, the adaptation of gut microbiota over time may be relevant, especially in comparing acute and long-term effects, but this remains to be determined. and intervention period also differed between the studies reviewed here. Moreover, inflammatory responses were assessed in different tissues (adipose tissue, duodenal tissue, muscle, PBMCs and whole blood), and the inflammatory markers that were screened also differed between the studies. Nevertheless, there is a lack of consensus regarding which biomarker is best for determining inflammation in human nutritional studies. 79 In this regard, a combination of multiple inflammatory markers appears to be more informative, 79 
